Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 282 Show results per page	View Search Criteria \| Help With Results


1.		Phase II-III Chemotherapy with BLEO/DTIC/VBL/ADR/PRED or NM/VCR/PCB/PRED Plus Radiotherapy for Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								DFCI-75100

Last Modified: 8/1/2005


2.		Phase II/III Chemotherapy with SZC/5-FU vs ADR/5-FU for Unresectable Carcinoid Tumors, with DTIC for Failures (Summary Last Modified 07/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				EST-1281

Last Modified: 2/15/2006


3.		Phase II/III Master Protocol for Chemotherapy with DTIC/ACT-D vs CACP/VBL/BLEO vs Phase II Agent with or without Prophylactic Cranial Radiotherapy for Disseminated Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				SWOG-8107

Last Modified: 5/1/1990


4.		Phase II/III Randomized Comparison of DTIC/BCNU/CDDP vs DTIC/BCNU/CDDP/TMX vs CDDP/TMX in Patients with Disseminated Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over								UCSD-88612 NCI-V89-0023

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				C023 ProMune, NCT00070642

Last Modified: 11/1/2006


6.		Phase I/III "6 in 1" Combination Chemotherapy (VCR/CACP/CTX/DTIC/VP-16/ADR) in Children over 365 Days Old with Previously Untreated Advanced Stage Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase I				Treatment				Closed				1 to 18				NCI				CCG-321P4

Last Modified: 10/1/2007 First Published: 4/1/1994


7.		Phase III Randomized Study of Radiotherapy With or Without Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) Versus ABVD Only in Patients With Stage I-IIA Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 and over				Other				CAN-NCIC-HD6 E-JHD06, NCI-V94-0427, NCT00002561, HD6, JHD06

Last Modified: 12/1/1997


8.		Phase III Randomized Study of Standard-Dose MAID (Mesna/DOX/IFF/DTIC) vs Dose-Intensified MAID with G-CSF for Advanced Adult Soft Tissue Sarcoma (Summary Last Modified 12/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 70								FRE-FNCLCC-PALSAR-93 NCI-F94-0018

Last Modified: 9/1/1996


9.		Phase III Randomized Study of Long-Term Adjuvant Therapy with Dacarbazine vs BCG vs Dacarbazine/BCG vs No Adjuvant Therapy for High-Risk Malignant Melanoma (Summary Last Modified 09/96)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 75								WHO-MEL-TRIAL6 EU-95043


10.		Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified								MSKCC-75104

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute